Clinical trials Coverage

Durham's Fortrea teams up with Medidata to improve diversity in clinical trials

The "Intelligent Trials" technology focuses on the feasibility of studies, and providing diversity data to aid companies in meeting representative enrollment targets.

Startup Spotlight: Durham's Velocity Clinical Research celebrates opening of first NC site

On a hot Thursday afternoon in August, Velocity staff was celebrating the opening of its most recent site in Durham by sponsoring a back-to-school event at Eastway Elementary School.

Duke U. spinout Clinetic plans to step up development of clinical trials tech

Clinetic, a Duke University spinout focused on linking hospital data with clinical studies, has created a platform that makes it possible for researchers to use data from hospital electronic health records (EHRs) to improve patient recruitment for clinical trials as well as gain more insights into the data.

Durham clinical health data startup Clinetic raises new cash

Clinetic, a life science startup focusing on patient recruitment for clinical trials and related data, says it has closed its Series A funding round with the backing of Sopris Capital. Here are the details.

Transforming clinical trials is goal for Duke Clinical Research Institute, UK partner

Duke Clinical Research Institute and Protas, a not-for-profit clinical trials organization based in the United Kingdom, have launched a long-term collaboration to transform clinical research by altering the way clinical trials are designed and delivered to better meet the needs of patients and society.

Durham-based Velocity: We're world's 'largest clinical research network' after latest deal

Velocity Clinical should incorporate "High" into its name as in "high velocity growth" after the Durham-based firm announced the latest - and largest - acquisition to date early Thursday.

Thoughtful analysis of market data and customer insights allows local biotech company to stay focused on the needs of patients

Relentless, early and often data collection and insight generation allowed BioCryst to anticipate and strategically leverage information for the good of patients -- a true competitive advantage and foundation for company success.

Thoughtful analysis of market data and customer insights allows local biotech company to stay focused on the needs of patients

Relentless, early and often data collection and insight generation allowed BioCryst to anticipate and strategically leverage information for the good of patients -- a true competitive advantage and foundation for company success.

Abbey Slattery, WRAL Digital Solutions

How putting patients at the center improves biotech clinical operations

By incorporating patient perspectives into the early stages of clinical trial development, BioCryst is working to improve the patient experience.

Abbey Slattery, WRAL Digital Solutions

Calif. company to move HQ, jobs averaging $114,000 in pay to Triangle

Science 37, Inc., a life science company focusing on clinical trials, is moving its headquarters to Morrisville from Culver City, Calif. and bringing along with it some 250 jobs paying an average minimum wage of more than $114,000.

Duke doctor provides update in vaccine trial for young children

Dr. Anthony Moody spoke 1 on 1 with WRAL's Debra Morgan Tuesday to further explain the trail.

It's Clinical Trials Day - here's a look at how far the industry has come in 274 years

Clinical Trials first appeared in 1747, and in the 274 years since then, they have progressed exponentially in terms of technology. Here's a look at the history.

CliniSpan Health brings diversification to clinical health trials

Chapel Hill-based startup CliniSpan Health is working to increase the presence of minorities in clinical health trials. 

UNC recruiting children for Novavax COVID-19 trial

Novavax is looking for children between the ages of 12 and 17 for its COVID-19 vaccine trial at UNC.

Drug trial aims to help people quit smoking

A Raleigh testing site is part of a clinical trial for a medication called "Cytisinicline," which is currently licensed in eastern Europe but not in the U.S. The medication is tailored to target nicotine receptors in the brain.

Wake study seeks smokers for trial of a medication that targets nicotine addiction

A smoking habit is not only expensive and unhealthy, it can be deadly. Most smokers know quitting could be life-saving if they just could.

Monica Laliberte, WRAL executive producer/5 on Your Side reporter

New effort partners with 100+ Triangle barbershops for COVID clinical trial

Rise Above COVID, a nationwide movement, partners with nearly 100 Black-owned barbershops and beauty salons in the Raleigh-Durham area to raise awareness and encourage enrollment in a clinical trial called ACTIV-2.

Family asks for 'Easter miracle,' access to ALS drug for mother

Lisa Stockman Mauriello is asking Biogen to allow her to try Tofersen, a drug currently in clinical trials, but the drug maker is denying early use until the trials are complete.

Joe Fisher, WRAL reporter

Moderna begins vaccine trial in children

A Duke Health spokeswoman said they are not participating in the Moderna trial, but Duke expects to begin enrolling children between the ages 5 and 11 in a Pfizer vaccine trial by the end of the month.

ECU doc: Vaccine makers progress with care in testing vaccines in kids

A Duke Health spokeswoman said they are not participating in the Moderna trial, but Duke expects to begin enrolling children between the ages 5 and 11 in a Pfizer vaccine trial by the end of the month.

Cullen Browder, WRAL reporter

Moderna's initial vaccine results 'more than hoped for,' says UNC expert

Dr. Cindy Gay, who oversees the clinical trial of Moderna's coronavirus vaccine candidate at UNC-Chapel Hill, says she was the high initial efficacy rate shown by the drug "was more than we were hoping for."

Triangle doctors share different experiences from vaccine trial

Drs. Nirmish and Sandy Shah both participated in the clinical trial for Moderna's potential coronavirus vaccine and had different experiences.

'It means some hope that we are going to beat this thing'

A second experimental COVID-19 vaccine - this one from Moderna Inc. - yielded extraordinarily strong early results Monday, another badly needed dose of hope as the pandemic enters a terrible new phase.

2nd virus vaccine shows striking success in US tests

A second experimental COVID-19 vaccine -- this one from Moderna Inc. -- yielded extraordinarily strong early results Monday, another badly needed dose of hope as the pandemic enters a terrible new phase.

By LAURAN NEERGAARD, AP Medical Writer

Duke infectious disease expert part of Pfizer vaccine trial

An infectious disease specialist at Duke University Hospital is one of the 44,000 people enrolled in Pfizer's clinical trials of a potential coronavirus vaccine.

Joe Fisher, WRAL multimedia journalist